Extraosseous plasmacytoma with an aggressive course occurring solely in the CNS.

Neuropathology

Department of Pathology & Laboratory Medicine, University of California, Irvine, Irvine, California, USA.

Published: June 2013

AI Article Synopsis

  • Extraosseous plasmacytoma is a rare, slow-growing tumor that makes up a small percentage of plasma cell neoplasms, typically occurring outside of bones.
  • Reports of these tumors in the central nervous system (CNS) are uncommon and are usually linked to other nasal lesions.
  • This case study highlights an aggressive form of extraosseous plasmacytoma in an HIV-positive patient, uniquely presenting in the CNS with evidence of EBV expression, manifested as both a brain mass and in cerebrospinal fluid (CSF).

Article Abstract

Extraosseous (extramedullary) plasmacytoma is a relatively indolent neoplasm that constitutes 3-5% of all plasma cell neoplasms. Rare cases have been reported to truly occur in the CNS and not as an extension from a nasal lesion. EBV expression in plasma cell neoplasms has been reported in very few cases that are mainly post-transplant or occurring in severely immunosuppressed patients. We report a case of extraosseous plasmacytoma with an aggressive course in an HIV-positive individual that occurred solely in the CNS, showing EBV expression by in situ hybridization, and presenting as an intraparenchymal mass as well as in the CSF.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1789.2012.01352.xDOI Listing

Publication Analysis

Top Keywords

extraosseous plasmacytoma
8
plasmacytoma aggressive
8
aggressive course
8
solely cns
8
plasma cell
8
cell neoplasms
8
ebv expression
8
course occurring
4
occurring solely
4
cns extraosseous
4

Similar Publications

Pleural thickening can be the result of inflammation or infection but can also have a neoplastic origin. Depending on the clinical context, a pleural lesion or mass is often initially suspected of malignancy. Benign pleural tumors are rare, and their appearance on ultrasound (US) is also described less frequently than pleural metastases or malignancies.

View Article and Find Full Text PDF

Multiple myeloma (MM) remains incurable despite novel therapeutics. A major contributor to the development of relapsed/refractory and resistant MM is extraosseous extramedullary disease (EMD), whose molecular biology is still not fully understood. We analyzed 528 MM patients who presented to our institution between 2014 and 2021 and who had undergone molecular testing.

View Article and Find Full Text PDF

Extra-medullary Plasmacytomas: A Case Series of Rare Hematological Tumors.

Cureus

November 2024

Department of Hematology, Agadir Faculty of Medicine and Pharmacy, Agadir, MAR.

Solitary plasmacytoma is a rare malignant tumor belonging to the family of plasma cell proliferation. It accounts for a small portion of plasma cell tumors and remains a rare condition. We report three cases of rare extraosseous plasmacytomas in young patients.

View Article and Find Full Text PDF

A solitary extraosseous plasmacytoma is a rare type of plasma cell neoplasm. Its occurrence in the stomach is particularly unusual and can easily be mistaken for more common types of tumors. We describe a case involving a solitary extraosseous plasmacytoma in a patient who experienced weight loss as the sole symptom.

View Article and Find Full Text PDF

Septal plasmacytoma: Dilemma of diagnosis.

Med J Armed Forces India

June 2024

Associate Professor, Department of ENT, Armed Forces Medical College, Pune, India.

Article Synopsis
  • Plasmacytomas are harmful tumors formed by the unusual growth of plasma cells and can occur in bones or soft tissues, with extramedullary types being rare, especially in the head and neck region.
  • An 80-year-old male was treated for a localized plasmacytoma in the nasal septum, successfully removed via endoscopic surgery, followed by radiation therapy, and has shown no signs of recurrence after one year.
  • Effective management of plasmacytomas requires a teamwork approach for diagnosis and treatment, and it's crucial to check for any broader systemic involvement before confirming a diagnosis of solitary plasmacytoma.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!